C19H14BrF4N5O5 — CID 58558410
4-(3-bromo-4-fluorophenyl)-3-[4-[2-oxo-2-[1-(2,2,2-trifluoroacetyl)piperidin-4-yl]ethyl]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one (PubChem CID 58558410) has the molecular formula C19H14BrF4N5O5 and a molecular weight of 548.25 g/mol. Its IUPAC name is 4-(3-bromo-4-fluorophenyl)-3-[4-[2-oxo-2-[1-(2,2,2-trifluoroacetyl)piperidin-4-yl]ethyl]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one.
| Compound Name | 4-(3-bromo-4-fluorophenyl)-3-[4-[2-oxo-2-[1-(2,2,2-trifluoroacetyl)piperidin-4-yl]ethyl]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one |
|---|---|
| PubChem CID | 58558410 |
| Molecular Formula | C19H14BrF4N5O5 |
| Molecular Weight | 548.25 g/mol |
| Exact Mass | 547.01 |
| IUPAC Name | 4-(3-bromo-4-fluorophenyl)-3-[4-[2-oxo-2-[1-(2,2,2-trifluoroacetyl)piperidin-4-yl]ethyl]-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one |
| SMILES | O=C(Cc1nonc1-c1noc(=O)n1-c1ccc(F)c(Br)c1)C1CCN(C(=O)C(F)(F)F)CC1 |
| InChI | InChI=1S/C19H14BrF4N5O5/c20-11-7-10(1-2-12(11)21)29-16(27-33-18(29)32)15-13(25-34-26-15)8-14(30)9-3-5-28(6-4-9)17(31)19(22,23)24/h1-2,7,9H,3-6,8H2 |
| InChIKey | VCFLRBQLFYHULI-UHFFFAOYSA-N |
| XLogP | 2.69 |
| TPSA | 124.33 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 548.25 |
| LogP ≤ 5 | 2.69 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |